Advertisement

Topics

Iroko Pharmaceuticals, LLC Company Profile

04:45 EDT 28th August 2016 | BioPortfolio

Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed products on a global basis through focused selling and marketing efforts and product-life-cycle management activities including development of new formulations to improve patient treatment.


News Articles [1273 Associated News Articles listed on BioPortfolio]

Louis J. Vollmer Named Iroko’s CEO

Iroko Pharmaceuticals LLC. has appointed Louis J. Vollmer president and CEO. Vollmer has been president of Iroko since March 2015...    

Iroko names Louis Vollmer president, CEO

David SalazarVollmer, who has been Iroko’s president since March 2015 has been in the pharmaceutical industry for more than 25 years, including his role as one of three founders of Endo Pharmace...

Iroko Pharmaceuticals Appoints Louis J. Vollmer as President and Chief Executive Officer

PHILADELPHIA, July 11, 2016 /PRNewswire/ -- Iroko Pharmaceuticals, LLC announced today the appointment of Louis J. Vollmer as President and Chief Executive Officer effective July 6, 2016. Mr. Vol...

Iroko Pharmaceuticals Secures Debt Financing From CRG

PHILADELPHIA, June 29, 2016 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company...

Lisa Nolan Joins Rexahn Pharmaceuticals

Cancer focused Rexahn Pharmaceuticals Inc. has appointed Lisa Nolan to the newly created position of chief business officer (CBO). She...   &#

Survey: Patients with pain cannot identify NSAIDs, do not discuss pain with their physicians

Although an Iroko Pharmaceuticals-funded survey of 1,056 American adults showed 77% of those surveyed experienced at least some type of pain and 43% experienced pain weekly, half of respondents were u...

Iroko financial update

Iroko Pharmaceuticals to Present Phase 3 VIVLODEX® Efficacy and Safety Data at World Congress of Osteoarthritis

PHILADELPHIA, March 31, 2016 /PRNewswire/ -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that it will pr...

Drugs and Medications [0 Results]

None

PubMed Articles [146 Associated PubMed Articles listed on BioPortfolio]

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Removal of pharmaceuticals from secondary effluents by an electro-peroxone process.

This study compared the removal of pharmaceuticals from secondary effluents of wastewater treatment plants (WWTPs) by conventional ozonation and the electro-peroxone (E-peroxone) process, which involv...

Ranking Prescribed Pharmaceuticals in Terms of Environmental Risk: Inclusion of Hospital Data and the Importance of Regular Review.

A newly available dataset on pharmaceuticals used in Scottish hospitals enabled an Environmental Risk Assessment that includes hospital consumption of pharmaceuticals, as previous UK rankings have bee...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin and propranolol, in Daphnia magna.

The objective of the present study was to investigate the uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin (ROX) and propranolol (PRP), in Daphnia magna via aqueous expos...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.

This study evaluates the frequency of occurrence, severity, and response to treatment by a chemical agent, notably the dimerizer AP1903 (Bellicum Pharmaceuticals compagny), in the case of ...

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

The purpose of this study is to compare the safety and efficacy profiles of Watson Laboratories, Inc.'s Pimecrolimus Cream, 1% to those of Valeant Pharmaceuticals North America LLC's Elide...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

TOL-463 Phase 2 Study

This is a Phase II randomized single blind (investigator-blinded) safety and efficacy study in approximately 90 adult females 18-50 years of age (to achieve 80 evaluable participants) at t...

Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)

This phase III clinical study will be conducted in Brazilian research sites. It will be included in the study 314 participants diagnosed with primary knee OA according to the classificatio...

Companies [5 Associated Companies listed on BioPortfolio]

Iroko Pharmaceuticals, LLC

Iroko is a pharmaceutical company focused on specialty therapeutic areas. The company acquires, develops and maximizes the potential of currently marketed products on a global bas...

Iroko Pharmaceuticals, LLC and SynopiaRx LLC

Iroko is a pharmaceutical company focused on the development and commercialization of innovative specialty therapeutic products. The company acquires, develops and maximizes the p...

Iroko Cardio International Sàrl

IROKO Cardio has been founded to organize and support the commercial effort for Aggrastat. In close cooperation with our worldwide distribution partners, we aim to provide state o...

Iroko Pharmaceuticals Inc.

Iroko Pharmaceuticals, LLC and Aptuit Inc.

More Information about "Iroko Pharmaceuticals, LLC" on BioPortfolio

We have published hundreds of Iroko Pharmaceuticals, LLC news stories on BioPortfolio along with dozens of Iroko Pharmaceuticals, LLC Clinical Trials and PubMed Articles about Iroko Pharmaceuticals, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Iroko Pharmaceuticals, LLC Companies in our database. You can also find out about relevant Iroko Pharmaceuticals, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record